Literature DB >> 17881359

p53 is a key molecular target of ursodeoxycholic acid in regulating apoptosis.

Joana D Amaral1, Rui E Castro, Susana Solá, Clifford J Steer, Cecília M P Rodrigues.   

Abstract

p53 plays an important role in regulating expression of genes that mediate cell cycle progression and/or apoptosis. In addition, we have previously shown that the hydrophilic bile acid ursodeoxycholic acid (UDCA) prevents transforming growth factor beta1-induced p53 stabilization and apoptosis in primary rat hepatocytes. Therefore, we hypothesized that p53 may represent an important target in bile acid-induced modulation of apoptosis and cell survival. In this study we demonstrated that UDCA reduces p53 transcriptional activity, thereby preventing its ability to induce Bax expression, mitochondrial translocation, cytochrome c release, and apoptosis in primary rat hepatocytes. More importantly, bile acid inhibition of p53-induced apoptosis was associated with decreased p53 DNA binding activity. Subcellular localization of p53 was also altered by UDCA. Both events appear to be related with increased association between p53 and its direct repressor, Mdm-2. In conclusion, these results further clarify the antiapoptotic mechanism of UDCA and suggest that modulation of Mdm-2/p53 interaction is a prime target for this bile acid.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17881359     DOI: 10.1074/jbc.M704075200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  27 in total

Review 1.  The role of MDM2-p53 axis dysfunction in the hepatocellular carcinoma transformation.

Authors:  Hui Cao; Xiaosong Chen; Zhijun Wang; Lei Wang; Qiang Xia; Wei Zhang
Journal:  Cell Death Discov       Date:  2020-06-19

2.  Identification of microRNAs during rat liver regeneration after partial hepatectomy and modulation by ursodeoxycholic acid.

Authors:  Rui E Castro; Duarte M S Ferreira; Xiaoxiao Zhang; Pedro M Borralho; Aaron L Sarver; Yan Zeng; Clifford J Steer; Betsy T Kren; Cecília M P Rodrigues
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-08-05       Impact factor: 4.052

3.  Deoxycholic acid modulates cell death signaling through changes in mitochondrial membrane properties.

Authors:  Tânia Sousa; Rui E Castro; Sandra N Pinto; Ana Coutinho; Susana D Lucas; Rui Moreira; Cecília M P Rodrigues; Manuel Prieto; Fábio Fernandes
Journal:  J Lipid Res       Date:  2015-09-08       Impact factor: 5.922

Review 4.  The immunophysiology and apoptosis of biliary epithelial cells: primary biliary cirrhosis and primary sclerosing cholangitis.

Authors:  Kazuhito Kawata; Yoshimasa Kobayashi; M Eric Gershwin; Christopher L Bowlus
Journal:  Clin Rev Allergy Immunol       Date:  2012-12       Impact factor: 8.667

5.  Insights into the mechanisms underlying the antiproliferative potential of a Co(II) coordination compound bearing 1,10-phenanthroline-5,6-dione: DNA and protein interaction studies.

Authors:  Daniel V Luís; Joana Silva; Ana Isabel Tomaz; Rodrigo F M de Almeida; Miguel Larguinho; Pedro V Baptista; Luísa M D R S Martins; Telma F S Silva; Pedro M Borralho; Cecília M P Rodrigues; António S Rodrigues; Armando J L Pombeiro; Alexandra R Fernandes
Journal:  J Biol Inorg Chem       Date:  2014-01-31       Impact factor: 3.358

6.  Antibiotic treatment is superior to ursodeoxycholic acid on total parenteral nutrition associated hepatic dysfunction.

Authors:  Cüneyt Günşar; Seda Vatansever; Ahmet Var; Reha Aygören; Omer Yilmaz; Elgin Türköz; Aydin Sencan; Erol Mir
Journal:  Pediatr Surg Int       Date:  2010-02-21       Impact factor: 1.827

7.  Bile Acid Toxicity and Protein Kinases.

Authors:  Atilla Engin
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

8.  Gender modifies the effect of ursodeoxycholic acid in a randomized controlled trial in colorectal adenoma patients.

Authors:  Patricia A Thompson; Betsy C Wertheim; Denise J Roe; Erin L Ashbeck; Elizabeth T Jacobs; Peter Lance; María Elena Martínez; David S Alberts
Journal:  Cancer Prev Res (Phila)       Date:  2009-12-01

9.  Switch from Mnt-Max to Myc-Max induces p53 and cyclin D1 expression and apoptosis during cholestasis in mouse and human hepatocytes.

Authors:  Heping Yang; Tony W H Li; Kwang Suk Ko; Meng Xia; Shelly C Lu
Journal:  Hepatology       Date:  2009-03       Impact factor: 17.425

10.  The oncoprotein HBXIP modulates the feedback loop of MDM2/p53 to enhance the growth of breast cancer.

Authors:  Hang Li; Qian Liu; Zhen Wang; Runping Fang; Yu Shen; Xiaoli Cai; Yuen Gao; Yinghui Li; Xiaodong Zhang; Lihong Ye
Journal:  J Biol Chem       Date:  2015-07-30       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.